Literature DB >> 20588320

Gabapentin suppresses cortical spreading depression susceptibility.

Ulrike Hoffmann1, Ergin Dileköz, Chiho Kudo, Cenk Ayata.   

Abstract

Cortical spreading depression (CSD) is an intense depolarization wave implicated in the pathophysiology of brain injury states and migraine aura. As Ca(v)2.1 channels modulate CSD susceptibility, we tested gabapentin, which inhibits Ca(v)2.1 through high-affinity binding to its alpha(2)delta subunit, on CSD susceptibility in anesthetized rats. Gabapentin, 100 or 200 mg/kg, elevated the electrical threshold for CSD and diminished recurrent CSDs evoked by topical KCl, when administered 1 hour before testing. With its favorable safety and tolerability profile, gabapentin may have a role in suppression of injury depolarizations in stroke, intracranial hemorrhage, and traumatic brain injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20588320      PMCID: PMC2949257          DOI: 10.1038/jcbfm.2010.92

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  16 in total

1.  Gabapentin inhibits presynaptic Ca(2+) influx and synaptic transmission in rat hippocampus and neocortex.

Authors:  Johannes A van Hooft; John J Dougherty; Duco Endeman; Robert A Nichols; Wytse J Wadman
Journal:  Eur J Pharmacol       Date:  2002-08-09       Impact factor: 4.432

2.  Vasoconstrictive neurovascular coupling during focal ischemic depolarizations.

Authors:  Hwa Kyoung Shin; Andrew K Dunn; Phillip B Jones; David A Boas; Michael A Moskowitz; Cenk Ayata
Journal:  J Cereb Blood Flow Metab       Date:  2005-12-07       Impact factor: 6.200

3.  The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain.

Authors:  J C Hunter; K R Gogas; L R Hedley; L O Jacobson; L Kassotakis; J Thompson; D J Fontana
Journal:  Eur J Pharmacol       Date:  1997-04-18       Impact factor: 4.432

4.  Suppression of cortical spreading depression in migraine prophylaxis.

Authors:  Cenk Ayata; Hongwei Jin; Chiho Kudo; Turgay Dalkara; Michael A Moskowitz
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

5.  The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel.

Authors:  N S Gee; J P Brown; V U Dissanayake; J Offord; R Thurlow; G N Woodruff
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

6.  P/Q Ca2+ channel blockade stops spreading depression and related pyramidal neuronal Ca2+ rise in hippocampal organ culture.

Authors:  Phillip E Kunkler; Richard P Kraig
Journal:  Hippocampus       Date:  2004       Impact factor: 3.899

7.  A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma.

Authors:  B H Stewart; A R Kugler; P R Thompson; H N Bockbrader
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

8.  Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.

Authors:  L L Radulovic; D Türck; A von Hodenberg; K O Vollmer; W P McNally; P D DeHart; B J Hanson; H N Bockbrader; T Chang
Journal:  Drug Metab Dispos       Date:  1995-04       Impact factor: 3.922

9.  Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate.

Authors:  D F Welty; G P Schielke; M G Vartanian; C P Taylor
Journal:  Epilepsy Res       Date:  1993-12       Impact factor: 3.045

10.  Preliminary evidence that ketamine inhibits spreading depolarizations in acute human brain injury.

Authors:  Oliver W Sakowitz; Karl L Kiening; Kara L Krajewski; Asita S Sarrafzadeh; Martin Fabricius; Anthony J Strong; Andreas W Unterberg; Jens P Dreier
Journal:  Stroke       Date:  2009-06-11       Impact factor: 7.914

View more
  7 in total

Review 1.  P/Q-type calcium channel modulators.

Authors:  V Nimmrich; G Gross
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 2.  Pharmacological targeting of spreading depression in migraine.

Authors:  Katharina Eikermann-Haerter; Anil Can; Cenk Ayata
Journal:  Expert Rev Neurother       Date:  2012-03       Impact factor: 4.618

3.  In vivo imaging reveals that pregabalin inhibits cortical spreading depression and propagation to subcortical brain structures.

Authors:  Stuart M Cain; Barry Bohnet; Jeffrey LeDue; Andrew C Yung; Esperanza Garcia; John R Tyson; Sascha R A Alles; Huili Han; Arn M J M van den Maagdenberg; Piotr Kozlowski; Brian A MacVicar; Terrance P Snutch
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-21       Impact factor: 11.205

4.  Gabapentin reduces infarct volume but does not suppress peri-infarct depolarizations.

Authors:  Ulrike Hoffmann; Jeong Hyun Lee; Tao Qin; Katharina Eikermann-Haerter; Cenk Ayata
Journal:  J Cereb Blood Flow Metab       Date:  2011-04-20       Impact factor: 6.200

5.  Microglial Calcium Waves During the Hyperacute Phase of Ischemic Stroke.

Authors:  Lei Liu; Kathryn N Kearns; Ilyas Eli; Khadijeh A Sharifi; Sauson Soldozy; Elizabeth W Carlson; Kyle W Scott; M Filip Sluzewski; Scott T Acton; Kenneth A Stauderman; M Yashar S Kalani; Min Park; Petr Tvrdik
Journal:  Stroke       Date:  2020-11-09       Impact factor: 7.914

Review 6.  Pregabalin as a Pain Therapeutic: Beyond Calcium Channels.

Authors:  Sascha R A Alles; Stuart M Cain; Terrance P Snutch
Journal:  Front Cell Neurosci       Date:  2020-04-15       Impact factor: 5.505

Review 7.  Cortical spreading depression as a target for anti-migraine agents.

Authors:  Cinzia Costa; Alessandro Tozzi; Innocenzo Rainero; Letizia Maria Cupini; Paolo Calabresi; Cenk Ayata; Paola Sarchielli
Journal:  J Headache Pain       Date:  2013-07-23       Impact factor: 7.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.